Similar articles for PMID: 29330751

Year	Number of Results
1982	1
1984	1
1988	1
1990	1
1993	4
1994	1
1995	3
1996	2
2001	1
2002	2
2003	1
2004	3
2005	5
2006	4
2007	2
2008	5
2009	7
2010	8
2011	8
2012	14
2013	17
2014	17
2015	20
2016	19
2017	13
2018	26
2019	35
2020	38
2021	26
2022	10
2023	6
2024	0

1

Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.

Youland RS, Pafundi DH, Brinkmann DH, Lowe VJ, Morris JM, Kemp BJ, Hunt CH, Giannini C, Parney IF, Laack NN. Youland RS, et al. J Neurooncol. 2018 May;137(3):583-591. doi: 10.1007/s11060-018-2750-7. Epub 2018 Jan 13. J Neurooncol. 2018. PMID: 29330751 Free PMC article. Clinical Trial.

2

Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.

Pafundi DH, Laack NN, Youland RS, Parney IF, Lowe VJ, Giannini C, Kemp BJ, Grams MP, Morris JM, Hoover JM, Hu LS, Sarkaria JN, Brinkmann DH. Pafundi DH, et al. Neuro Oncol. 2013 Aug;15(8):1058-67. doi: 10.1093/neuonc/not002. Epub 2013 Mar 3. Neuro Oncol. 2013. PMID: 23460322 Free PMC article.

3

Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.

Fueger BJ, Czernin J, Cloughesy T, Silverman DH, Geist CL, Walter MA, Schiepers C, Nghiemphu P, Lai A, Phelps ME, Chen W. Fueger BJ, et al. J Nucl Med. 2010 Oct;51(10):1532-8. doi: 10.2967/jnumed.110.078592. Epub 2010 Sep 16. J Nucl Med. 2010. PMID: 20847166 Free article.

4

¹⁸F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study.

Patel CB, Fazzari E, Chakhoyan A, Yao J, Raymond C, Nguyen H, Manoukian J, Nguyen N, Pope W, Cloughesy TF, Nghiemphu PL, Czernin J, Lai A, Ellingson BM. Patel CB, et al. J Neurooncol. 2018 Sep;139(2):399-409. doi: 10.1007/s11060-018-2877-6. Epub 2018 Apr 20. J Neurooncol. 2018. PMID: 29679199 Free PMC article.

5

Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?

Pöpperl G, Kreth FW, Herms J, Koch W, Mehrkens JH, Gildehaus FJ, Kretzschmar HA, Tonn JC, Tatsch K. Pöpperl G, et al. J Nucl Med. 2006 Mar;47(3):393-403. J Nucl Med. 2006. PMID: 16513607 Free article. Clinical Trial.

6

High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.

Kosztyla R, Chan EK, Hsu F, Wilson D, Ma R, Cheung A, Zhang S, Moiseenko V, Benard F, Nichol A. Kosztyla R, et al. Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1100-6. doi: 10.1016/j.ijrobp.2013.09.008. Epub 2013 Oct 22. Int J Radiat Oncol Biol Phys. 2013. PMID: 24161427

7

Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.

Bette S, Gempt J, Delbridge C, Kirschke JS, Schlegel J, Foerster S, Huber T, Pyka T, Zimmer C, Meyer B, Ringel F. Bette S, et al. World Neurosurg. 2016 May;89:230-9. doi: 10.1016/j.wneu.2016.01.085. Epub 2016 Mar 9. World Neurosurg. 2016. PMID: 26855307

8

The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.

Bashir A, Brennum J, Broholm H, Law I. Bashir A, et al. J Neurosurg. 2018 Apr 6;130(2):451-464. doi: 10.3171/2017.8.JNS171577. J Neurosurg. 2018. PMID: 29624154

9

Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience.

Evangelista L, Cuppari L, Bellu L, Bertin D, Caccese M, Reccia P, Zagonel V, Lombardi G. Evangelista L, et al. Curr Radiopharm. 2019;12(3):220-228. doi: 10.2174/1874471012666190115124536. Curr Radiopharm. 2019. PMID: 30644351 Review.

10

Diagnostic value of fusion of metabolic and structural images for stereotactic biopsy of brain tumors without enhancement after contrast medium injection.

Todeschi J, Bund C, Cebula H, Chibbaro S, Lhermitte B, Pin Y, Lefebvre F, Namer IJ, Proust F. Todeschi J, et al. Neurochirurgie. 2019 Dec;65(6):357-364. doi: 10.1016/j.neuchi.2019.08.002. Epub 2019 Sep 24. Neurochirurgie. 2019. PMID: 31560911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

266 results

Results by year